Trillium Therapeutics Inc.’s Post

Trillium Therapeutics Inc. · 2021-08-23T10:47:23.132Z

We are excited to announce that we have entered into a definitive agreement under which Pfizer will acquire Trillium Therapeutics. Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-622 and TTI-621, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system. https://lnkd.in/gt7ispka

Sign in or join now to see Trillium Therapeutics Inc.’s post

This post is unavailable.

Join now Sign in

5,051 followers

View Profile Connect

Explore topics

Sales
Marketing
IT Services
Business Administration
HR Management
Engineering
Soft Skills
See All

翻译：